Incyte Agreement with CMS Aims to Expand Medicaid Access to Jakafi
Incyte entered an agreement with the U.S. Centers for Medicare & Medicaid Services that will enable state Medicaid programs to access Jakafi and Jakafi XR at prices aligned with those in a defined group of advanced industrialized nations. Incyte expects protection from certain future CMS pricing mandates and says it will not materially affect 2026 financial guidance.